Free Trial

M�nchener R�ckversicherungs-Gesellschaft (OTCMKTS:MURGY) Receives Consensus Recommendation of "Hold" from Analysts

M�nchener R�ckversicherungs-Gesellschaft logo with Finance background

Key Points

  • Münchener Rückversicherungs-Gesellschaft has received a consensus recommendation of "Hold" from six research firms, with five analysts rating it as such and one giving a strong buy.
  • Keefe, Bruyette & Woods downgraded the company from "hold" to a "moderate sell" in a recent research note.
  • The firm reported earnings of $0.36 per share for the latest quarter, surpassing analysts' expectations of $0.30, although revenues fell short at $16.76 billion against expected $22.83 billion.
  • Five stocks to consider instead of M�nchener R�ckversicherungs-Gesellschaft.

Shares of M�nchener R�ckversicherungs-Gesellschaft (OTCMKTS:MURGY - Get Free Report) have been given a consensus rating of "Hold" by the six analysts that are covering the stock, Marketbeat Ratings reports. Five research analysts have rated the stock with a hold rating and one has issued a strong buy rating on the company.

Separately, Keefe, Bruyette & Woods lowered shares of M�nchener R�ckversicherungs-Gesellschaft from a "hold" rating to a "moderate sell" rating in a research report on Friday, June 6th.

Get Our Latest Research Report on M�nchener R�ckversicherungs-Gesellschaft

M�nchener R�ckversicherungs-Gesellschaft Price Performance

Shares of MURGY traded down $0.11 during mid-day trading on Monday, reaching $12.35. 449,792 shares of the stock traded hands, compared to its average volume of 205,233. The firm has a fifty day moving average price of $13.16 and a 200 day moving average price of $12.85. The company has a market cap of $80.67 billion, a price-to-earnings ratio of 5.69, a price-to-earnings-growth ratio of 1.58 and a beta of 0.69. The company has a current ratio of 1.13, a quick ratio of 1.14 and a debt-to-equity ratio of 0.20. M�nchener R�ckversicherungs-Gesellschaft has a 1 year low of $9.72 and a 1 year high of $14.41.

M�nchener R�ckversicherungs-Gesellschaft (OTCMKTS:MURGY - Get Free Report) last released its quarterly earnings results on Friday, August 8th. The financial services provider reported $0.36 EPS for the quarter, beating analysts' consensus estimates of $0.30 by $0.06. M�nchener R�ckversicherungs-Gesellschaft had a net margin of 8.37% and a return on equity of 15.88%. The firm had revenue of $16.76 billion during the quarter, compared to analyst estimates of $22.83 billion. As a group, equities research analysts predict that M�nchener R�ckversicherungs-Gesellschaft will post 0.46 earnings per share for the current year.

About M�nchener R�ckversicherungs-Gesellschaft

(Get Free Report)

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München engages in the insurance and reinsurance businesses worldwide. It also offers life and health reinsurance solutions, such as digital underwriting and advanced analytics solutions, health insurance management system, financial market risks, financing, portfolio risk management, digitalized investment-linked solution, MIRA digital suite, MIRA POS, MIRApply insured and physician, claims risk adjustment, CLARA plus, data analytics, underwriting and claims, medical research, capital management, and health market.

Further Reading

Analyst Recommendations for M�nchener R�ckversicherungs-Gesellschaft (OTCMKTS:MURGY)

Should You Invest $1,000 in M�nchener R�ckversicherungs-Gesellschaft Right Now?

Before you consider M�nchener R�ckversicherungs-Gesellschaft, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and M�nchener R�ckversicherungs-Gesellschaft wasn't on the list.

While M�nchener R�ckversicherungs-Gesellschaft currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.